{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:47:32Z","timestamp":1775638052759,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jvs.2021.05.049","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T03:59:16Z","timestamp":1624593556000},"page":"2030-2039.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management"],"prefix":"10.1016","volume":"74","author":[{"given":"Hataka R.","family":"Minami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan K.","family":"Itoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Garcia-Toca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2021.05.049_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.05.049_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2021.05.049_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)06089-9","article-title":"Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Zheng","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2021.05.049_bib4","first-page":"492","article-title":"Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis","volume":"29","author":"Xu","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.2018.8357","article-title":"Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2021.05.049_bib6","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2021.05.049_bib8","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2021.05.049_bib9","doi-asserted-by":"crossref","first-page":"381.e1","DOI":"10.1016\/j.amepre.2010.11.021","article-title":"Atherosclerotic cardiovascular disease screening in adults: American College Of Preventive Medicine position statement on preventive practice","volume":"40","author":"Lim","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2021.05.049_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2018.06.091","article-title":"Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: an Australian perspective","volume":"270","author":"Ademi","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib14","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/2047487320913380","article-title":"Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study","volume":"27","author":"Petersohn","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/2047487318817910","article-title":"Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: an Australian healthcare perspective","volume":"26","author":"Zomer","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib16","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.jacc.2019.04.046","article-title":"Association of multiple enrichment criteria with ischemic and bleeding risks among COMPASS-eligible patients","volume":"73","author":"Darmon","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib17","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.jacc.2019.02.079","article-title":"Rivaroxaban plus aspirin versus aspirin in relation to vascular risk in the COMPASS trial","volume":"73","author":"Anand","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","article-title":"US norms for six generic health-related quality-of-life indexes from\u00a0the National Health Measurement study","volume":"45","author":"Fryback","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jvs.2021.05.049_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jchf.2013.12.003","article-title":"Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)","volume":"2","author":"Lewis","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jvs.2021.05.049_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1262-3636(07)70154-4","article-title":"Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments","volume":"30","author":"Redekop","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jvs.2021.05.049_bib21","doi-asserted-by":"crossref","first-page":"e0211493","DOI":"10.1371\/journal.pone.0211493","article-title":"Health-related quality of life loss associated with first-time stroke","volume":"14","author":"Yeoh","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2021.05.049_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2478\/s11536-012-0118-5","article-title":"Health-related quality of life in patients after the acute myocardial infarction","volume":"8","author":"Ran\u010di\u0107","year":"2013","journal-title":"Open Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.162.5.553","article-title":"Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography","volume":"162","author":"Pilote","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12955-018-1019-3","article-title":"Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study","volume":"16","author":"Doble","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jvs.2021.05.049_bib25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2012.12.002","article-title":"High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease","volume":"165","author":"Jones","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2021.05.049_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCOUTCOMES.108.775247","article-title":"One-year costs in patients with a history of or at risk for atherothrombosis in the United States","volume":"1","author":"Mahoney","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jvs.2021.05.049_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2021.05.049_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib33","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2106\/JBJS.F.01350","article-title":"Health-care costs associated with amputation or reconstruction of a limb-threatening injury","volume":"89","author":"MacKenzie","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2021.05.049_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1310\/tsr18s01-676","article-title":"Cost associated with stroke: outpatient rehabilitative services and medication","volume":"18","author":"Godwin","year":"2011","journal-title":"Top Stroke Rehabil"},{"key":"10.1016\/j.jvs.2021.05.049_bib35","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jamainternmed.2013.10789","article-title":"Growth in Medicare expenditures for patients with acute myocardial infarction: a comparison of 1998 through 1999 and 2008","volume":"173","author":"Likosky","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jvs.2021.05.049_bib36","first-page":"751","article-title":"Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants","volume":"22","author":"Rozjabek","year":"2019","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jvs.2021.05.049_bib38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0735-1097(94)90596-7","article-title":"Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease","volume":"23","author":"Eagle","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2021.05.049_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/STROKEAHA.110.601831","article-title":"Hospital-level variation in mortality and rehospitalization for Medicare beneficiaries with acute ischemic stroke","volume":"42","author":"Fonarow","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2021.05.049_bib41","first-page":"417","article-title":"Lower extremity amputation in peripheral artery disease: improving patient outcomes","volume":"10","author":"Swaminathan","year":"2014","journal-title":"Vasc Health Risk Manag"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521421010028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521421010028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:35:46Z","timestamp":1760042146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521421010028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0741521421010028"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2021.05.049","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2021.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}